Compare CASY & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CASY | RMD |
|---|---|---|
| Founded | 1959 | 1989 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4B | 28.4B |
| IPO Year | 1994 | N/A |
| Metric | CASY | RMD |
|---|---|---|
| Price | $852.86 | $224.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $696.50 | $292.56 |
| AVG Volume (30 Days) | 330.7K | ★ 1.3M |
| Earning Date | 06-08-2026 | 04-30-2026 |
| Dividend Yield | 0.29% | ★ 1.13% |
| EPS Growth | ★ 30.87 | N/A |
| EPS | ★ 19.16 | N/A |
| Revenue | ★ $17,561,101,000.00 | N/A |
| Revenue This Year | $9.54 | $10.60 |
| Revenue Next Year | $5.34 | $7.41 |
| P/E Ratio | $44.40 | ★ $25.61 |
| Revenue Growth | ★ 10.16 | N/A |
| 52 Week Low | $490.00 | $180.27 |
| 52 Week High | $927.85 | $293.81 |
| Indicator | CASY | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 65.42 |
| Support Level | $767.10 | $218.39 |
| Resistance Level | $893.25 | $233.75 |
| Average True Range (ATR) | 24.34 | 5.57 |
| MACD | -1.32 | 2.49 |
| Stochastic Oscillator | 51.00 | 92.81 |
Casey's General Stores Inc, along with its subsidiaries, operates convenience stores mainly under the names Casey's, GoodStop (by Casey's), and Casey's General Store throughout various states in the USA, approximately half of which are located in Iowa, Missouri, and Illinois. These stores offer a broad selection of food items (which includes prepared foods such as regular and breakfast pizza, donuts, hot breakfast items, and hot and cold sandwiches), beverages, tobacco and nicotine products, groceries, health and beauty aids, automotive products, and other non-food items. The majority of the company's revenue is mainly derived from the retail sale of fuel and the products offered inside its stores.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.